• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

    Cargill to Double Production of Tapioca Syrup

    Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences

    Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure

    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods

    Red Seaweed Digestive Supplement for Cattle Could Reduce Enteric Methane Emissions by 80%

    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients

    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

    Cargill to Double Production of Tapioca Syrup

    Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences

    Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Red Seaweed Digestive Supplement for Cattle Could Reduce Enteric Methane Emissions by 80%

    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults

    Vitamin Angels’ Mother’s Day Donation Campaign Raises Awareness for Maternal and Child Nutrition

    Bioiberica Forays into Two New Health Areas

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    KLK OLEO

    PhytoGaia Inc

    Nutrition21, LLC

    Botanic Healthcare LLC

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    KLK OLEO

    PhytoGaia Inc

    Nutrition21, LLC

    Botanic Healthcare LLC

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Federal Agencies Warn Company Marketing Unapproved CBD Products

    ‘These actions should send a message to the broader market about complying with FDA requirements,’ says Acting FDA Commissioner.

    Federal Agencies Warn Company Marketing Unapproved CBD Products
    Related CONTENT
    • Sunflower Hemp Co
    • CBD in the Clinic: How Practitioners View Life After the Farm Bill
    • The CBD Craze: Still Only the Beginning
    • Cannovia: Clearing Up CBD Market Confusion
    • Resveratrol: The Healthy Aging Nutrient
    10.22.19
    The U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, FL, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat teething pain and ear aches in infants, autism, attention-deficit/hyperactivity disorder (ADHD), as well as Parkinson’s and Alzheimer’s disease, among other conditions or diseases.
     
    “Cannabis and cannabis-derived compounds are subject to the same laws and requirements as FDA-regulated products that contain any other substance. We are working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat, or cure a number of diseases or conditions,” said Acting FDA Commissioner Ned Sharpless, MD.
     
    “This is especially concerning when companies are peddling unproven CBD products for use in vulnerable populations like infants and children,” he continued. “We’ve sent numerous warning letters that focus on matters of significant public health concern to CBD companies, and these actions should send a message to the broader market about complying with FDA requirements. As we examine potential regulatory pathways for the lawful marketing of cannabis products, protecting and promoting public health through sound, science-based decision-making remains our top priority. We appreciate the FTC joining us on these and other actions to protect consumers from fraudulent CBD products.”
     
    As described in the warning letter issued to Rooted Apothecary, the company used product webpages, through its online store and social media websites, to make unfounded claims about its CBD products, and some of the products were also unlawfully marketed as dietary supplements. The agency has determined that CBD products cannot be marketed as dietary supplements.
     
    Examples of the unsupported claims made by the company include:
     
    “Instead of synthetic chemical[s] that can have safety concerns, this blend uses the best of nature to help calm the inflammation and pain of teething, while also promoting sleepiness for your little one.”
     
    “No matter what age, ear aches are a terrible, no good way to live each day! Our main priority was safety, effectiveness ... as we formulated this for the entire family including our precious little ones. When the pain is bad, this roller goes to work for soothing pain, inflammation, and to battle against the bacterial/viral critters to blame.”
     
    “Increasing evidence suggests that CBD oil is a powerful option for pain ... anxiety ... and autism ... It seems like an attractive and safe option for children.”
     
    “CBD oil may have neuroprotective properties and may protect against neurological conditions, such as Parkinson’s and Alzheimer’s disease.”
     
    “[P]ossible uses for CBD include helping with skin problems such as acne, autism, ADHD, and even cancer. It’s often used in conjunction with traditional treatments to provide extra help. Children can use high amounts of CBD safely and without any risk.”
     
    Additionally, under the Federal Trade Commission Act, it is unlawful to advertise that a product can prevent, treat, or cure human disease unless the advertiser possesses competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made.
     
    More generally, to make or exaggerate such claims, whether directly or indirectly, through the use of a product name, website name, metatags, or other means, without rigorous scientific evidence sufficient to substantiate the claims, violates the FTC Act. The FTC is concerned that one or more of the efficacy claims cited may not be substantiated by competent and reliable scientific evidence.
     
    These products are also misbranded under the Federal Food, Drug, and Cosmetic (FD&C) Act, because the products’ labels and product information fail to include adequate directions for use. Drugs in the U.S. must contain directions explaining how a consumer can use a drug safely for its intended purpose. Under the law, there is an exemption for this labeling requirement for prescription drugs that have FDA-approved applications in effect. However, none of Rooted Apothecary’s products are FDA-approved.
     
    The FDA and FTC have requested responses from Rooted Apothecary within 15 working days stating how the company will correct the violations. Failure to correct the violations promptly may result in legal action, including product seizure and/or injunction. Violations of the FTC Act may result in legal action seeking a Federal District Court injunction or administrative cease and desist order, and an order also may require that a company pay back money to consumers.
     
    The FDA continues to be concerned about the proliferation of products claiming to contain CBD that are marketed for therapeutic or medical uses that have not been approved by the agency. The FDA approval process ensures that drugs on the market are safe and effective for their intended therapeutic uses.
     
    CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams. The FDA has not approved any CBD products other than one prescription human drug product to treat rare, severe forms of epilepsy. There is very limited information for other marketed CBD products, which likely differ in composition from the FDA-approved product and have not been evaluated for potential adverse effects on the body.
     
    The FDA continues to explore potential pathways for various types of CBD products to be lawfully marketed. An important component of this work is obtaining and evaluating information to address outstanding questions related to the safety of CBD products while maintaining the FDA’s rigorous public health standards.
     
    “The FDA is working quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD while using all available resources to monitor the marketplace and protect public health by taking action as needed against companies,” said FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD. “We recognize that there is significant public interest in cannabis and cannabis-derived compounds; however, we must work together to fill in the knowledge gaps about the science, safety and quality of many of these products. We are committed to advancing our regulation of these products through an approach that, in line with our mission, prioritizes public health, fosters innovation and promotes consumer confidence.”
     
    Unlike drugs approved by the FDA, the manufacturing process of unapproved CBD products has not been subject to FDA review as part of the drug approval process. Further, there has been no FDA evaluation of whether these products are effective for their intended use, what the proper dosage is, how they could interact with FDA-approved drugs, or whether they have dangerous side effects or other safety concerns. Consumers may put off getting important medical care, such as proper diagnosis, treatment and supportive care due to unsubstantiated claims associated with CBD products. For that reason, it’s important that consumers talk to a health care professional about the best way to treat diseases or conditions with existing, approved treatment options.
     
    The FDA has previously sent warning letters to other companies illegally selling CBD products that claimed to prevent, diagnose, treat or cure serious diseases, such as cancer. Some of these products were in further violation of the FD&C Act because they were marketed as dietary supplements or because they involved the addition of CBD to food.
     
    The FDA encourages healthcare professionals and consumers to report adverse reactions associated with these or similar products to the agency’s MedWatch program.
    Related Searches
    • Regulatory
    • Regulation
    • ADHD
    • Cancer
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    CBD in the Clinic: How Practitioners View Life After the Farm Bill CBD in the Clinic: How Practitioners View Life After the Farm Bill
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Resveratrol: The Healthy Aging Nutrient Resveratrol: The Healthy Aging Nutrient
    FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive
    Industry Calls for Label Literacy of New Supplement Facts Label Industry Calls for Label Literacy of New Supplement Facts Label
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    Charlotte’s Web Introduces Hemp Extract-Infused Gummies Charlotte’s Web Introduces Hemp Extract-Infused Gummies
    FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease
    Levagen PEA: A Legal Answer to CBD’s Issues Levagen PEA: A Legal Answer to CBD’s Issues
    FDA Warns Women of Childbearing Age to Avoid Vinpocetine FDA Warns Women of Childbearing Age to Avoid Vinpocetine
    Plant-Based Sweeteners Offer Natural Appeal Plant-Based Sweeteners Offer Natural Appeal
    Move Over Mainstream, Healthy Foods Are Here to Stay Move Over Mainstream, Healthy Foods Are Here to Stay
    DSHEA Discussion: Assessing Standards for Scientific Evidence DSHEA Discussion: Assessing Standards for Scientific Evidence

    Related Content

    • Sunflower Hemp Co

      ...
      Colby Terip, Owner 09.15.21

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

    • Consumer Trends | Healthcare Trends | Herbs & Botanicals | Mood Health & Sleep | Natural/Organic | Research
      The CBD Craze: Still Only the Beginning

      The CBD Craze: Still Only the Beginning

      Consumers are craving hemp products, and brands are set to deliver despite regulatory uncertainty.
      By Sean Moloughney, Editor, Nutraceuticals World 09.03.19


    • Herbs & Botanicals | Quality & Safety
      Cannovia: Clearing Up CBD Market Confusion

      Cannovia: Clearing Up CBD Market Confusion

      CEO Brian Baum discusses the future of CBD innovation and product development.
      By Sheldon Baker 08.30.19

    • Antioxidants | Cardiovascular Health | Cognitive Function | Diabetes & Blood Sugar Management | Research
      Resveratrol: The Healthy Aging Nutrient

      Resveratrol: The Healthy Aging Nutrient

      Market projected to see continued growth as product development accelerates.
      08.22.19

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Indena’s Meriva Curcumin Supplement May Benefit Kidney Function
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Test On Hydrolyzed Collagen Shows Resoundingly High Bioavailability | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      Breaking News
      • Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
      • Cargill to Double Production of Tapioca Syrup
      • Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences
      • Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure
      • Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
      Cargill to Double Production of Tapioca Syrup
      Southwest College of Naturopathic Medicine to Become Sonoran University of Health Sciences
      Coatings World

      Latest Breaking News From Coatings World

      The 13th International R-M Best Painter Contest Final Set for June 2022
      Jason Woods Joins The ChemQuest Group as Director
      Indorama Ventures Achieves Record 1Q22 Performance
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 14
      Teleflex Launches UroLift 2 System and UroLift ATC System in the U.S.
      ENDRA Life Sciences Achieves ISO 13485 Recertification
      Contract Pharma

      Latest Breaking News From Contract Pharma

      LOTTE to Purchase BMS East Syracuse NY Manufacturing Facility
      Bora Pharmaceuticals Acquires CDMO Assets from Eden Biologics
      Cytiva Opening New Facility in Switzerland
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      5 Packaging Execs Inducted into NJPEC Hall of Fame
      Nautica Unveils New Eco-Conscious, Alcohol-Free Fragrance
      Sigma Beauty Launches Clean Blushes, Bronzers and Highlighters
      Happi

      Latest Breaking News From Happi

      Dollar General Launches New Summer-Centric Body Care Lines
      Naturium Adds Sensitive Skin Care
      Proposed Senate FDA Legislation Includes Cosmetics Reform
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: INX’s New VC Fund, Flint Group and Siegwerk Lead This Week’s News
      The 2022 CPIPC Golf Outing Set for June 22
      NUtec’s NUbis Bulk Ink System Enables Continuous Printing
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      LemuGroup hosting Open House, Lynn Perenic honored and more
      PCMC and Hudson-Sharp assist Aspen Press & Packaging
      LemuGroup prepares for Open House in Spain
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Ontex Confirms Possibility of Attindas Deal, Purell Launches New Wipes & More
      TSG Finishing Starts Modernization Project
      Berry Global Sets New Target to Reduce Scope 3 Emissions
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—May 14
      Steven Haddad Joins Extremity Medical as Chief Clinical Officer
      FDA OKs Accelus' FlareHawk TiHawk11 Interbodies
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Graphene Flagship Launches Its First Customizable Wafer Run
      CCL Industries Announces 1Q 2022 First Quarter Results
      LG Display Showcases Innovative OLED Technology at SID 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login